Published in Hepatitis Weekly, October 7th, 1996
Interferon alfa (IFN-(alpha)) is the most successful drug currently in use for the treatment of liver disease caused by chronic hepatitis infection. Its most common side effect is an influenza-like syndrome that usually disappears after the first few treatment doses. Other possible toxicities, however, such as the induction of autoimmunity, are more dangerous.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.